Latest Tax Refunds News

Omega Oil and Gas has bolstered its balance sheet with a $46 million equity placement and confirmed the strong commercial potential of its Canyon Project, setting the stage for a major appraisal campaign in 2026.

Vitasora Health Limited reported robust patient program growth and secured new US partnerships, driving revenue above A$1 million for the quarter. A recent A$11 million capital raise positions the company for continued expansion and cash-flow breakeven by late 2026.

Imugene Limited reports an 81% overall response rate in its azer-cel CAR T-cell therapy trial for difficult lymphomas, alongside a $25 million capital raise that extends its cash runway to mid-2027.

BCAL Diagnostics has secured key partnerships and a $10 million convertible note facility to expand its cancer detection tests across Australia and New Zealand, marking steady commercial progress in Q3 2025.

Control Bionics reports a strong start to FY26 with nearly 10% revenue growth, expanded US reimbursement coverage, and advancing commercialization of its NeuroNode and NeuroStrip technologies.

Elixir Energy reports promising gas pay results at Diona-1 and secures a premium drilling rig for the upcoming Lorelle-3 appraisal well, positioning itself for a pivotal phase in the Taroom Trough.

Vectus Biosystems has signed a binding agreement to sell its VB4-P5 renal fibrosis compound to Canadian biotech XORTX Therapeutics, while actively pursuing licensing opportunities for its lead drug VB0004 and others, particularly in China.

Norwood Systems reports a second consecutive quarter of positive operating cash flow, enabling debt reduction and progress in key projects with Optus and Microsoft. The company also secured multiple industry awards, underscoring its innovation momentum.

Patrys Limited has raised $1.77 million through a fully underwritten entitlement offer to fund preclinical studies and business development for its deoxymab therapeutic antibodies. The company also completed a capital consolidation and held a successful AGM, signaling a strategic pivot into immunology and inflammation.

CONNEQT Health reported a $2.6 million operating cash outflow in the September quarter but secured $2 million through a convertible note, while expecting a $1.6 million R&D tax refund to shore up liquidity.

Aurora Labs has advanced its micro gas turbine propulsion program with critical durability testing, a new Defence contract phase, and a strategic $5.5 million capital raise to scale manufacturing and commercialisation.

Sparc Technologies has completed construction of a pioneering green hydrogen pilot plant and secured new patents, while its graphene additive trials show promising corrosion resistance results.